C12Y 304/22015
Cathepsin l
Official title: Cathepsin L (3.4.22.15)
C12Y304/22015 (Cathepsin l) appears on 7 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 7
- Published applications
- 12
- Assignees
- 7
- Inventors
- 28
- Latest grant
- 29 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 2 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 2 | 1 |
By publication year.
Recent patents
- Separation moieties and methods of use thereof29 Aug 2023US 11,739,132 B2Werewolf Therapeutics, Inc.
- Macrobrachium nipponense Cathepsin L gene, dsRNA thereof, and use thereof2 May 2023US 11,639,502 B2Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences
- Methods of treatment of collagen-mediated diseases and conditions5 Dec 2017US 9,833,498 B2Halozyme, Inc.
- Methods of treatment of cellulite3 Oct 2017US 9,775,889 B2Halozyme, Inc.
- Cathepsin L inhibitors and probes comprising vinyl sulfonate moiety and methods of using same1 Nov 2016US 9,481,876 B2Research Foundation of the City University of New York
- Separation moieties and methods of use thereof31 Aug 2023US 2023/0272028 A1
- Macrobrachium Nipponense Cathepsin L Gene, dsRNA Thereof, and Use Thereof10 Nov 2022US 2022/0356477 A1Freshwater Fisheries Research Center, Chinese Academy of Fishery Sciences
- Separation moieties and methods of use thereof14 Jul 2022US 2022/0220181 A1Werewolf Therapeutics, Inc.
- Separation moieties and methods of use thereof22 Apr 2021US 2021/0115102 A1Werewolf Therapeutics, Inc.
- Cathepsin l inhibitors and probes comprising vinyl sulfonate moiety and methods of using same26 Nov 2015US 2015/0337286 A1Research Foundation of the City University of New York
Most cited
By later US patents
- Methods of treatment of collagen-mediated diseases and conditions3US 9,833,498 B2Halozyme, Inc. · 2017
- Separation moieties and methods of use thereof1US 11,739,132 B2Werewolf Therapeutics, Inc. · 2023
- Human cathepsin L2 protein, gene encoding said protein and use thereof1US 6,800,473 B1Daiichi Fine Chemical Co., Ltd. · 2004
- Methods of treatment of cellulite1US 9,775,889 B2Halozyme, Inc. · 2017